| COMPOSITION: | Each tablet contains Dapagliflozin 10 mg & Linagliptin 5 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Dapaford-LN 5 is a Type-II anti diabetic medication which contains Dapagliflozin, acts by removing sugar from the body via urine to lower its level in blood & Linagliptin, a DPP4 inhibitor that acts on the intestinal enzyme to control diabetes. It is prescribed in adjunct to diet control, exercise & other drugs to control type II diabetes. |
| SIDE EFFECTS: | Low sugar levels, painful urination, repetitive urination, inflammation of penis, urinary tract infection & allergic reaction may occur in patients. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
